Idiopathic Cd4 Lymphocytopenia C3809768
A rare immune system disorder where certain white blood cells remain dangerously low without HIV infection. It can affect both children and adults, leading to increased infections and autoimmune problems. Treatment focuses on preventing infections and monitoring immune function.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pneumocystis jirovecii pneumonia
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Recurrent oral candidiasis
(mucocutaneous)Extensive warts
(integumentary)Autoimmune cytopenias
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antimicrobial Prophylaxis
Combination antimicrobial prophylaxis including trimethoprim-sulfamethoxazole for PCP prevention and azithromycin for MAC prophylaxis. Regular monitoring for signs of infection is essential given the severe immunodeficiency.
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
CD4 Count and Infection Surveillance
Regular monitoring of CD4+ T cell counts every 3-6 months along with comprehensive infection screening. Early detection of declining counts allows for timely intervention.
Additional treatment options
Intravenous Immunoglobulin Therapy
IVIG administration provides passive antibody replacement to help prevent bacterial and viral infections. Typically administered monthly or as clinically indicated based on infection frequency.
medicationInfection Prevention Practices
Implementation of rigorous hygiene measures including hand washing, food safety practices, and avoidance of exposure to sick individuals. Patient education on recognizing early infection signs.
lifestyleImmunonutrition Support
Nutritional supplementation with zinc, selenium, and vitamin D to support immune function. Adequate protein intake to maintain muscle mass and immune competence.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Idiopathic Cd4 Lymphocytopenia C3809768?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Idiopathic Cd4 Lymphocytopenia C3809768. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy